These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

771 related articles for article (PubMed ID: 24747563)

  • 21. MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes.
    Larter CZ; Yeh MM; Williams J; Bell-Anderson KS; Farrell GC
    J Hepatol; 2008 Sep; 49(3):407-16. PubMed ID: 18534710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. iPla2β Deficiency Suppresses Hepatic ER UPR, Fxr, and Phospholipids in Mice Fed with MCD Diet, Resulting in Exacerbated Hepatic Bile Acids and Biliary Cell Proliferation.
    Ming Y; Zhu X; Tuma-Kellner S; Ganzha A; Liebisch G; Gan-Schreier H; Chamulitrat W
    Cells; 2019 Aug; 8(8):. PubMed ID: 31409057
    [No Abstract]   [Full Text] [Related]  

  • 23. Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency.
    Kirsch R; Clarkson V; Verdonk RC; Marais AD; Shephard EG; Ryffel B; de la M Hall P
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):174-82. PubMed ID: 16706830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thioredoxin-binding protein-2 deficiency enhances methionine-choline deficient diet-induced hepatic steatosis but inhibits steatohepatitis in mice.
    Ahsan MK; Okuyama H; Hoshino Y; Oka S; Masutani H; Yodoi J; Nakamura H
    Antioxid Redox Signal; 2009 Oct; 11(10):2573-84. PubMed ID: 19764881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of treatment with hydrogen sulfide on methionine-choline deficient diet-induced non-alcoholic steatohepatitis in rats.
    Luo ZL; Tang LJ; Wang T; Dai RW; Ren JD; Cheng L; Xiang K; Tian FZ
    J Gastroenterol Hepatol; 2014 Jan; 29(1):215-22. PubMed ID: 24117897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alisol B 23-acetate protects against non-alcoholic steatohepatitis in mice via farnesoid X receptor activation.
    Meng Q; Duan XP; Wang CY; Liu ZH; Sun PY; Huo XK; Sun HJ; Peng JY; Liu KX
    Acta Pharmacol Sin; 2017 Jan; 38(1):69-79. PubMed ID: 27773935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis.
    Salamone F; Galvano F; Cappello F; Mangiameli A; Barbagallo I; Li Volti G
    Transl Res; 2012 Jun; 159(6):477-86. PubMed ID: 22633099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenovirus-mediated peroxisome proliferator activated receptor gamma overexpression prevents nutritional fibrotic steatohepatitis in mice.
    Nan YM; Han F; Kong LB; Zhao SX; Wang RQ; Wu WJ; Yu J
    Scand J Gastroenterol; 2011 Mar; 46(3):358-69. PubMed ID: 20969493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.
    Sahai A; Malladi P; Melin-Aldana H; Green RM; Whitington PF
    Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G264-73. PubMed ID: 15044174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice.
    Sugimoto H; Okada K; Shoda J; Warabi E; Ishige K; Ueda T; Taguchi K; Yanagawa T; Nakahara A; Hyodo I; Ishii T; Yamamoto M
    Am J Physiol Gastrointest Liver Physiol; 2010 Feb; 298(2):G283-94. PubMed ID: 19926817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gender Differences in Bile Acids and Microbiota in Relationship with Gender Dissimilarity in Steatosis Induced by Diet and FXR Inactivation.
    Sheng L; Jena PK; Liu HX; Kalanetra KM; Gonzalez FJ; French SW; Krishnan VV; Mills DA; Wan YY
    Sci Rep; 2017 May; 7(1):1748. PubMed ID: 28496104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of the nuclear receptor constitutive androstane receptor in the pathogenesis of non-alcoholic steatohepatitis.
    Yamazaki Y; Kakizaki S; Horiguchi N; Sohara N; Sato K; Takagi H; Mori M; Negishi M
    Gut; 2007 Apr; 56(4):565-74. PubMed ID: 16950832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary glycotoxins exacerbate progression of experimental fatty liver disease.
    Leung C; Herath CB; Jia Z; Goodwin M; Mak KY; Watt MJ; Forbes JM; Angus PW
    J Hepatol; 2014 Apr; 60(4):832-8. PubMed ID: 24316518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deficiency of Both Farnesoid X Receptor and Takeda G Protein-Coupled Receptor 5 Exacerbated Liver Fibrosis in Mice.
    Ferrell JM; Pathak P; Boehme S; Gilliland T; Chiang JYL
    Hepatology; 2019 Sep; 70(3):955-970. PubMed ID: 30664797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pathogenesis of ethanol versus methionine and choline deficient diet-induced liver injury.
    Gyamfi MA; Damjanov I; French S; Wan YJ
    Biochem Pharmacol; 2008 Feb; 75(4):981-95. PubMed ID: 18036573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor.
    Yang F; Huang X; Yi T; Yen Y; Moore DD; Huang W
    Cancer Res; 2007 Feb; 67(3):863-7. PubMed ID: 17283114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease.
    Pathil A; Mueller J; Warth A; Chamulitrat W; Stremmel W
    Hepatology; 2012 May; 55(5):1369-78. PubMed ID: 22183915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of iron overload in a rat nutritional model of non-alcoholic fatty liver disease.
    Kirsch R; Sijtsema HP; Tlali M; Marais AD; Hall Pde L
    Liver Int; 2006 Dec; 26(10):1258-67. PubMed ID: 17105592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Essential pathogenic and metabolic differences in steatosis induced by choline or methione-choline deficient diets in a rat model.
    Veteläinen R; van Vliet A; van Gulik TM
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1526-33. PubMed ID: 17716355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential hepatotoxicity of dietary and DNL-derived palmitate in the methionine-choline-deficient model of steatohepatitis.
    Pierce AA; Pickens MK; Siao K; Grenert JP; Maher JJ
    BMC Gastroenterol; 2015 Jun; 15():72. PubMed ID: 26103964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.